by Backoffice | May 25, 2023 | Collaborations
Cell2Cure has developed a stem cell product that does not require a tissue match between donor and patient and can simply be stored in the freezer for use in various clinical purposes. Cell2Cure was in continuation of the pres release visited – and researched...
by Backoffice | Feb 27, 2022 | Collaborations
Cell2Cure has entered into a collaboration agreement with Endeavour Cells ApS, to collaborate on the preparation, conduct, management, and completion of an un-blinded phase I/II clinical trial in children with autism. The clinical trial title is “Effect of adipose...
by Backoffice | Feb 12, 2022 | Collaborations
Cell2Cure has entered into a sublicense agreement with Endeavour Cells ApS, which will allow Endeavour Cells ApS to develop, manufacture and commercialize ASCs for the treatment of Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD),...
by Backoffice | Jul 10, 2021 | Collaborations
Cell2Cure (C2C) has entered into a collaboration agreement with Cbio A/S to establish C2C´s own GMP facility for production of adipose tissue-derived mesenchymal stromal cell products (ASCs) in Cbio´s newly established and approved cell production facility,...
by ICR-Web | Oct 1, 2020 | Collaborations
Cell2Cure, as part of the consortium Clinical Stem cell Innovation and production Center, CSIC, receives funding from Innovation Fund Denmark. CSIC embraces late-stage development of ASCs – it aims to mature process knowledge and product quality as a...
Recent Comments